ClinicalTrials.govpublic full text
An Open-label, Single-arm Clinical Study to Evaluate the Safety and Preliminary Efficacy of OriV508 Injection in Treating Relapsed/Refractory Hematological Malignancies
multiple myeloma (mm), non-hodgkin lymphoma (nhl), bcma/cd19, multiple myeloma, non-hodgkin lymphoma, in vivo car-t, interventional, early_phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 870811
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.